ClinicalTrials.govpublic full text
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
idiopathic pulmonary fibrosis, pulmonary hypertension, ph, ipf, ambrisentan, era, endothelin receptor antagonist, cardiovascular, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810204
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.